논문
1. Role of adjuvant postoperative external beam radiotherapy for well differentiated thyroid cancer. Kwon J, Wu HG, Youn YK, Lee KE, Kim KH, Park do J. Radiat Oncol J. 2013 Sep;31(3):162-70
2. Impact of multimodality approach for patients with leptomeningeal metastases from solid tumors. Kwon J, Chie EK, Kim K, Kim HJ, Wu HG, Kim IH, Oh DY, Lee SH, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ, Ha SW. J Korean Med Sci. 2014 Aug;29(8):1094-101.
3. Additional survival benefit of involved-lesion radiation therapy after R-CHOP chemotherapy in limited stage diffuse large B-cell lymphoma. Kwon J, Kim IH, Kim BH, Kim TM, Heo DS. Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):91-8.
4. Survival Benefit of Adjuvant Chemoradiotherapy in Patients With Ampulla of Vater Cancer: A Systematic Review and Meta-analysis. Kwon J, Kim BH, Kim K, Chie EK, Ha SW. Ann Surg. 2015 Jul;262(1):47-52.
5. Prognostic Value of Log Odds of Positive Lymph Nodes after Radical Surgery Followed by Adjuvant Treatment in High-risk Cervical Cancer. Kwon J, Eom KY, Kim IA, Kim JS, Kim YB, No JH, Kim K. Cancer Res Treat. 2016 Apr;48(2):632-40.
6. Objective Measurement of Cosmetic Outcomes of Breast Conserving Therapy Using BCCT.core. Yu T, Eom KY, Jang NY, Kim KS, Koo TR, Kwon J, Kim BH, Kang E, Kim SW, Kim JS, Kim IA. Cancer Res Treat. 2016 Apr;48(2):491-8.
7. The prognostic impacts of postoperative radiotherapy in the patients with resected anaplastic thyroid carcinoma: A systematic review and meta-analysis. Kwon J, Kim BH, Jung HW, Besic N, Sugitani I, Wu HG. Eur J Cancer. 2016 May 12.
8. The Prognostic Importance of the Number of Metastatic Lymph Nodes for Patients Undergoing Curative Resection Followed by Adjuvant Chemoradiotherapy for Extrahepatic Bile Duct Cancer. Kim BH, Kim K, Chie EK, Kwon J, Jang JY, Kim SW, Han SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW. J Gastrointest Surg. 2015 Oct;19(10):1833-41.
9. Targeting Phosphatidylinositol 4-Kinase IIIa for Radiosensitization: A Potential Model of Drug Repositioning Using an Anti-Hepatitis C Viral Agent. Kwon J, Kim DH, Park JM, Park YH, Hwang YH, Wu HG, Shin KH, Kim IA. Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):867-876
10. A Prognostic Model for Patients with Triple-Negative Breast Cancer: Importance of the Modified Nottingham Prognostic Index and Age. Kwon J, Eom KY, Koo TR, Kim BH, Kang E, Kim SW, Kim YJ, Park SY, Kim IA. J Breast Cancer. 2017 Mar;20(1):65-73
11. Long-term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-year Experience in a Single Institution. Kim BH, Kim K, Chie EK, Kwon J, Jang JY, Kim SW, Oh DY, Bang YJ. Cancer Res Treat. 2017 Apr;49(2):473-483
12. Impact of Resection Margin Distance on Survival of Pancreatic Cancer: a Systematic Review and Meta-Analysis. Kim KS, Kwon J, Kim K, Chie EK. Cancer Res Treat. 2017 Jul; 49(3): 824–833.
13. Failure patterns according to molecular subtype in patients with invasive breast cancer following postoperative adjuvant radiotherapy: long-term outcomes in contemporary clinical practice. Lim YJ, Lee SW, Choi N, Kwon J, Eom KY, Kang E, Kim EK, Kim SW, Kim JH, Kim YJ, Kim SH, Park SY, Kim JS, Kim IA. Breast Cancer Res Treat. 2017 Jun;163(3):555-563
14. Risk stratification and prognostic nomogram for post-recurrence overall survival in patients with recurrent extrahepatic cholangiocarcinoma. Kim BH, Kim K, Chie EK, Kwon J, Jang JY, Kim SW, Oh DY, Bang YJ. HPB (Oxford). 2017 May;19(5):421-428
15. Evaluation of the Benefit of Radiotherapy in Patients with Occult Breast Cancer: A Population-based Analysis of the SEER Database. Kim BH, Kwon J, Kim K. Cancer Res Treat. 2017 Jun 1.
16. Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment. Kwon J, Kim K, Chie EK, Kim BH, Jang JY, Kim SW, Oh DY, Bang YJ. Eur J Surg Oncol. 2017 Sep;43(9):1690-1696. doi: 10.1016/j.ejso.2017.05.024
17. The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-stage Cervical Cancer with High Risk Factors - a Multicenter Cohort Study (KROG 15-04). Kwon J, Eom KY, Kim YS, Park W, Chun M, Lee J, Kim YB, Yoon WS, Kim JH, Choi JH, Chang SK, Jeong BK, Lee SH, Cha J. Cancer Res Treat. 2017 Oct 24.
